Clinical data | |
---|---|
Trade names | Primolut-Nor, Aygestin, Gestakadin, Milligynon, Monogest, Norlutate, Primolut N, SH-420, Sovel, Styptin |
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a604034 |
Routes of administration |
Oral |
Legal status | |
Legal status |
|
Identifiers | |
|
|
Synonyms | SH-420 |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C22H28O3 |
Molar mass | 340.456 g/mol |
3D model (Jmol) | |
|
|
|
|
(what is this?) |
Norethisterone acetate (NETA) (INN, BAN), also known as norethindrone acetate (USAN), sold under brand names including Primolut-Nor (major), Aygestin (US), Gestakadin, Milligynon, Monogest, Norlutate (US, CA), Primolut N, SH-420 (UK), Sovel, Styptin, and others, is a steroidal progestin of the 19-nortestosterone group with additional weak androgenic and estrogenic activity that is used orally as a hormonal contraceptive, in the treatment of gynecological disorders such as abnormal uterine bleeding, and as a component of hormone replacement therapy for menopause. It is the 17β-acetate ester of norethisterone, and acts as a prodrug to norethisterone in the body.
Upon oral ingestion, NETA is rapidly converted into norethisterone by esterases during intestinal and first-pass hepatic metabolism. Hence, it is a prodrug of norethisterone in the body. As such, NETA is a potent progestogen with additional weak androgenic and estrogenic activity (the latter via its metabolite ethinylestradiol).